GH1 and pituitary tumor: Previous research has demonstrated that FLNA, an actin cross-linking protein, is the substrate of different phospho-kinases, and that it might prevent somatostatin receptor 2 (SST2) from regulating in GH-secreting pituitary tumor by means of being promoted by cAMP pathway and inhibited by somatostatin analogs (SSA) [63].